Back to search
Carbapenem Resistant Bacteria Infection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Carbapenem Resistant Bacteria Infection trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Carbapenem Resistant Bacteria Infection trials you may qualify forRates of antimicrobial resistance are increasing worldwide. There is increasing evidence that physiological gut microbiota is a large reservoir of antibiotic-re…
This is a retrospective, observational, post-marketing study to evaluate the clinical response, microbiological response, mortality, and safety of intravenous p…
Antibiotic resistance (AR) is a critical public health threat and one of the greatest challenges of the 21st century. In an estimate of 2019, nearly 700.000 inf…
This clinical trial aims to compare two methods of administering polymyxin B for treating severe brain infections caused by carbapenem-resistant Gram-negative b…
The goal of this observational study is to investigate how bacterial populations from the intestine and mouth of patients change during the hospitalization peri…
Pulmonary infection is a kind of infectious disease that seriously damages human health. It usually starts quickly and progresses rapidly in clinical manifestat…
This study evaluates the efficacy in achieving clinical cure in non-bacteremic urinary tract infections (UTI) caused by Escherichia coli or Klebsiella pneumonia…